| Financial Year |
March 31 2023 |
| Monetary Funds |
17,305,352,814.67 |
| Held-for-trading Financial Assets |
42,266,319.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
240,290,939.81 |
| Advances to Suppliers |
18,662,077.24 |
| Other Receivables |
976,236,593.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,739,003,849.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
905,321,991.39 |
| Total Current Assets |
42,228,596,056.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,274,271,381.26 |
| Investment Properties |
8,177,603,543.43 |
| Fixed Assetes |
370,866,786.04 |
| Under-construction Projects |
98,571,985.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
11,627,262.38 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,384,293.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
39,496,631.08 |
| Deferred Income Tax Assets |
1,482,772,396.74 |
| Other Non-Current Assets |
4,828,786,541.40 |
| Sub-Total of Non-Current Assets |
18,420,401,115.34 |
| Total Assets |
60,648,997,171.88 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,543,119,015.81 |
| Accounts Received In Advance |
31,146,082.19 |
| Employee Compensation Payable |
123,308,594.81 |
| Taxes Payable |
4,374,434,220.23 |
| Interest Payable |
-- |
| Dividend Payable |
1,336,950.94 |
| Other payables |
1,516,074,960.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,716,310,499.11 |
| Other Current Liabilities |
941,784,356.37 |
| Sub-Total of Current Liabilities |
21,375,171,344.51 |
| Long-term Loans |
9,516,844,947.91 |
| Bonds Payable |
13,258,326,240.23 |
| Long-Term Accounts Payable |
99,177,927.05 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,723,179.45 |
| Deferred Income Tax Liabilities |
14,650,369.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,176,779,640.78 |
| Total Liabilities |
44,551,950,985.29 |
| Paid-In Capital(Or Share Stock) |
6,096,135,252.00 |
| Capital Surplus |
2,244,977,586.39 |
| Surplus Reserve |
902,039,570.36 |
| LESS:Treasury Stock |
162,388,649.81 |
| Undistributed Profits |
5,884,803,664.31 |
| Minority Stockholder's Interest |
1,130,564,888.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,966,481,298.25 |
| Owner's Equity（Stockholder's Equity） |
16,097,046,186.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
60,648,997,171.88 |
